Huge focal nodular hyperplasia presenting in a 6-year-old child: A case presentation  by Zhuang, Lin et al.
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INTRODUCTION:  Focal  nodular  hyperplasia  (FNH)  is  a benign  lesion  of the  liver  which  is usually  found
in  healthy  adults,  however,  FNH  is rare  in  children,  and  comprises  only  2% of  all pediatric  liver  tumors.
Herein,  we  report  the case  of a 6-year-old  child (male)  with  a huge  FNH  which  size is more  than  10  cm.
This  could  be the  biggest  FNH  among  all  children’s  FNH  cases  ever  reported.
CASE  PRESENTATION:  A  6-year-old  boy  was  found  a  hepatic  space-occupying  lesion  two  years  ago.  As the
time  went  by,  the lesion  became  bigger  gradually.  The  last  CT examination  showed  the  size  of  the  tumorocal nodular hyperplasia
hild
enign liver tumors
omputed tomography
to  be  10.5  ×  9.9  cm in  the  right  hepatic  lobe.  This  child  underwent  surgical  resection  of the  tumor  which
was  conﬁrmed  as  FNH  (11  × 8 ×  7 cm)  by pathology.
CONCLUSION:  FNH  is  a benign  lesion  of the  liver, and it is characterized  by hepatocyte  hyperplasia  and  a
central  stellate  scar.  It is  uncommon  for  FNH  to be  diagnosed  in children.  Such  huge FNH  (about  11 cm)
is extremely  rare.  Surgical  operation  may  be  the effective  method  to cure  huge  FNH.
©  2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Primary tumors of the liver, including malignant and benign
umors, constitute 1%–2% of all pediatric tumors [1]. Focal nodu-
ar hyperplasia (FNH) is a benign lesion of the liver which is usually
ound in healthy adults [2]; however, FNH is rare in children, and
omprises only 2% of all pediatric liver tumors [3]. FNH is a well-
ircumscribed and lobulated tumor, which is often asymptomatic
nd incidentally discovered [4]. On gross examination, the typical
rchitecture of FNH includes bile ducts and a central stellate scar,
hich also contains blood vessels that supply the hyperplastic pro-
ess. Microscopically, the proliferating cells are almost identical to
he surrounding hepatocytes [5]. Chen et al. [6] showed children
ith an indeﬁnite diagnosis should undergo surgical treatment.
erein, we managed a 6-year-old boy with a huge FNH. The diag-
osis could not be established based on imaging studies and needle
iopsy, thus the boy underwent a surgical procedure.Abbreviations: FNH, focal nodular hyperplasia; ALT, alanine aminotransferase;
ST, aspartate aminotransferase; CT, computed tomography.
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2. Case report
A healthy 6-year-old boy was  referred to us for evaluation
of a hepatic space-occupying lesion, which was ﬁrst detected
approximately 2 years ago. Imaging studies, including abdomi-
nal ultrasound and computed tomography (CT), were performed
2 years ago. An abdominal ultrasound scan revealed a 6.1 × 5.2 cm
lesion with inhomogeneous and a well-demarcated low echo in the
right lobe of the liver. On CT image of the upper abdomen, a plain
scan showed a 6.5 × 5.4 cm circular shadow with a slightly low den-
sity in the right hepatic lobe, which displayed a central star-like
scar in the low-density area. On the contrast CT scan, the shadow
was more prominent in the arterial phase and decreased slightly
in the venous phase. In the delayed phase, the density was  close
to the liver parenchyma and the lower-density area disappeared in
the right hepatic lobe. The tentative diagnoses were FNH or hepato-
blastoma based on imaging. The patient was  referred to our hospital
for further therapy. He had no symptoms of nausea or vomiting.
The physical examination showed mild hepatomegaly. Laboratory
testing in our hospital revealed the following: alanine aminotrans-
ferase (ALT) and aspartate aminotransferase (AST) were 23.2 U/L
(normal, 15–40 U/L) and 37.0 U/L (normal, 9–50 U/L), respectively;
viral serologic tests for hepatitis B and C were negative; and the
alpha-fetoprotein (AFP) level was 0.7 ng/ml.
During hospitalization, the re-examination showed that the
lesion had enlarged slightly. The patient had CT in our hospital,
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. (A) Plain scan showed the lesion was  low density with a lower density scar show
without central scar tissues and showed a clear capsule. (C) The lesion was decreased in t
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aig. 2. Gross pathology of the resected tumor shows an 11-cm tumor with a round-
ike appearance, compatible with the imaging features.
hich showed the size of the shadow to be 10.5 × 9.9 cm in the right
epatic lobe and the spleen was slightly larger. A dynamic CT scan of
he liver disclosed a lobulated tumor with several expanded feeding
essels in the right hepatic lobe. On arterial and portal venous phase
maging, the tumor continued to exhibit a brightly enhanced early
hase and early washout (Fig. 1). Next, we invited a pediatrician
o perform the needle biopsy in our hospital; however, the diagno-
is was still indeterminate after the histologic examination. Thus,
e decided to intervene surgically to obtain a deﬁnite pathologic
iagnosis. During surgery, a well-deﬁned mass was  palpated in the
ight posterior lobe of the liver. The texture of the mass was hard,
nd the diameter was approximately 7 cm.  Combined with the pre-
perative imaging examination, the intra-operative diagnosis was
NH. Thus, we  decided to perform a partial hepatectomy.
On the gross pathologic examination of the surgical speci-
en, the tumor was shown to be enlarged in the right posterior
iver, well-deﬁned, yellow-to-tan in color, and 11 × 8 × 7 cm in size,
ith numerous small nodes on the surface of the liver tumor
Fig. 2). Microscopically, we observed a huge non-encapsulated
umor (10.5 × 8 × 6.5 cm), which consisted of a proliferation of bile
ucts and a central stellate scar containing tortuous blood vessels.
he pathologic ﬁndings were consistent with FNH (Fig. 3). Post-
peratively, the child was recovering well at the 6-month follow-up
isit.. Discussion
Among pediatric primary liver neoplasms, 57% are malignant
nd 43% are benign [5]. FNH belongs to benign in children withed in the center. (B) In the arterial phase, the lesion was signiﬁcantly enhanced
he venous phase.
liver diseases. and FNH is usually diagnosed between 2 and 5 years
of age [7]. Nevertheless, case reports involving children >5 years of
age are still rare worldwide.
FNH is an uncommon diagnosis in children, and is often found
incidentally [8–12]. The etiology of these lesions is unclear, with
possibilities including vascular or environmental factors [10,13,14].
Like other benign liver tumors, small lesions can be asymptomatic
incidental ﬁndings. Larger lesions eventually present with numer-
ous symptoms, the most frequent of which is abdominal pain. On
examination, the child usually presents with a right upper abdom-
inal mass [15]. Although normal levels of AFP suggest a benign
lesion, laboratory tests are usually unremarkable [16]. In this case
report, the 6-year-old boy had no obvious abdominal symptoms
when he came to our hospital and the physical examination just
showed mild hepatomegaly and the tumor-marker test of AFP is
normal (0.7 ng/ml).
FNH of the liver, which is a nodular, non-encapsulated, occa-
sionally multifocal (15%-20%) liver mass, most frequently occurs
in the left liver lobe [17]. Abdominal ultrasound is often used as
the initial diagnostic imaging modality. Ultrasound is non-speciﬁc
and FNH typically appears as a homogeneous, well-circumscribed
lesion that can be isoechoic, hypoechoic, or hyperechoic [11]. The
typical central scar is slightly hyperechoic, but is often difﬁcult to
visualize on ultrasound (20% of cases) [18]. Ungermann et al. [19]
showed that contrast-enhanced ultrasonography can be the ﬁnal
diagnostic method for FNH >3 cm in size with a typical spoke-wheel
vessel structure. If this phenomenon is not present and the central
scar is not visible, a speciﬁc diagnosis of FNH cannot be based solely
on contrast-enhanced ultrasound ﬁndings. The tumor has charac-
teristics which are more speciﬁc and can aid in the diagnosis on CT
scan after intravenous contrast enhancement. On pre-contrast CT
scans, FNH is often seen as s focal hypo- or iso-dense mass. Some
statistics have shown that a central hypodense scar is observed
in only one-third of cases [18]. FNH typically demonstrates uni-
form enhancement with IV contrast administration and enhances
more than normal liver tissue. In most cases (89%–100%), the lesion
enhances rapidly during the arterial phase of contrast-enhanced
CT because of the prominent arterial supply to FNH [20]. In our
case, the typical central scar was  not noted on ultrasound imaging
which was taken two  years ago; however, the central scar was  seen
on CT. Nevertheless, the diagnosis of CT was uncertain, which was
compatible with the pathologic results.
Thus far, no histologic reports have shown that FNH undergoes
malignant progression; however, cases of FNH lesions associ-
ated with hepatocellular carcinoma (HCC) do exist [21–23]. Petsas
et al. [23] reported a case of HCC arising within a large FNH. The
patient underwent pre-operative CT-guided core needle biopsy
that revealed FNH; however, the ﬁnal pathologic diagnosis dis-
closed FNH and HCC. Based on this case, we  understand that
although radiographic imaging could have a particular ﬁnding, liver
biopsy or resection might be necessary to establish the diagnosis
effectively. Makhlouf et al. [24] reported that it is necessary to have
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Fig. 3. (A–B) Well-deﬁned, non-encapsulated tumor, composed of nodular hepatocytes with “cirrhosis-like” architecture, separated by ﬁbrous septa. Numerous duct-like
structure proliferations with scattered lymphocytes (hematoxylin & eosin, 40X). (C) Architectural disturbance caused by ﬁbrous septa linking portal tracts (Masson staining,
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H00X). (D) Immunostaining for CK7 shows ductular reaction and phenotypic swit
CK7  immunostaining, 100X). (E) Immunostaining for CD34 shows a large sum of
mmunostaining for Ki-67 shows the lower expression of proliferation (<1%, Ki-67 i
 needle biopsy when there is any doubt about the diagnosis by
maging, however, only a quarter of the cases could be correctly
iagnosed at this time. In this case, we invited a pediatrician from
ur hospital to perform the needle biopsy to establish the diag-
osis; however, this attempt failed because of the lack of typical
istologic characteristics of FNH. Yang et al. [9] suggested that for
ediatric FNH patients, active surgical treatment by hepatectomy
hould be performed if the patient has the following: (1) clinical
ymptoms; (2) indeﬁnite diagnosis or hepatitis B virus carriage; (3)
umor size >5 cm.  In this case, the patient is in accordance with (2)
nd (3), so, the child accepted surgery treatment.
. Conclusion
It is occasional for children to have FNH without symptoms. We
sually use imaging examinations to ensure the diagnosis of FNH.
ometimes, it is difﬁcult for us to differentiate from other benign
nd malignant tumors in children. Needle biopsy will be necessary
o have when there is any doubt about the diagnosis by imaging.
owever, when the diagnosis of FNH is still unclear by imaging of the hepatocytic cytokeratins, reﬂecting long-standing intrahepatic cholestasis
lar endothelial cells which proliferated widely (CD34 immunostaining, 100X). (F)
nostaining, 100X).
examinations and needle biopsy, surgical treatment should be con-
sidered.
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